Vahedi F, Odenstedt J, Hartford M, Gilljam T, Bergfeldt L. Vectorcardiography analysis of the repolarization response to pharmacologically induced autonomic nervous system modulation in healthy subjects. J Appl Physiol 113: 368 -376, 2012. First published May 10, 2012 doi:10.1152/japplphysiol.01190.2011.-Autonomic nervous system activity is essential for regulation of ventricular repolarization (VR) and plays an important role in several arrhythmogenic conditions. This study in 31 healthy adult subjects (16 men, 15 women) evaluated the VR response to pharmacologically modulated autonomic nervous system activity applying vectorcardiography (VCG) analysis. During continuous VCG recording, 0.01-0.1 g·kg Ϫ1 ·min Ϫ1 isoprenaline (Iso) was infused at an increasing flow rate until three targeted heart rates (HR) were reached. After Iso washout, one intravenous bolus of 0.04 mg/kg atropine was given followed by an intravenous bolus of 0.2 mg/kg propranolol. A 5-min steady-state VCG recording was analyzed for each of the seven phases (including baseline 1 and 2). Furthermore, during the first 4 min following atropine, six periods of 10-s VCG were selected for subanalysis to evaluate the time course of change. The analysis included QRS, QT, and T-peak to T-end intervals, measures of the QRS and T vectors and their relation, as well as T-loop morphology parameters. By increasing HR, Iso infusion decreased HR dependent parameters reflecting total heterogeneity of VR (T area) and action potential morphology (ventricular gradient). In contrast, Iso prolonged QT HR corrected according to Bazett and increased the T-peak to T-end-to-QT ratio to levels observed in arrhythmogenic conditions. HR acceleration after atropine was accompanied by a transient paradoxical QT prolongation and delayed HR adaptation of T area and ventricular gradient. In addition to the expected HR adaptation, the VR response to ␤-adrenoceptor stimulation with Iso and to muscarinic receptor blockade with atropine thus included alterations previously observed in congenital and acquired long QT syndromes, demonstrating substantial overlap between physiological and pathophysiological electrophysiology.
INCREASED HETEROGENEITY OF ventricular repolarization (VR) and refractoriness creates a substrate for arrhythmias (13) . Such heterogeneity is primarily due to differences in action potential morphology throughout the ventricles superimposed on secondary factors such as differences in ventricular depolarization instants and can be assessed by the ventricular gradient (VG) (7) . The concept was first introduced by Wilson et al. in 1934 as "the area of QRST" (32) . Vectorcardiography (VCG), based on Wilson's concepts, was developed in the early 1950s for use in routine analysis of ECG tracings (9) , but neither VG nor VCG has become widely applied for clinical purposes. The VG concept has, however, attracted theoretical interest. Further studies have proven that VG (also QRST area or QRST integral) is an index of ventricular heterogeneity of action potential morphology and can be calculated as the vector sum of the QRSarea (the spatial area under the curve formed by the moving heart vector during the QJ interval, an index of heterogeneity in depolarization instants) and Tarea (the spatial area under the curve formed by the moving heart vector during the JT interval, an index of global heterogeneity of VR) (8) .
The need for a method allowing noninvasive evaluation of other aspects of the human VR apart from its duration, such as its heterogeneity, has persisted. When QT dispersion was found to be less than ideal for the evaluation of VR heterogeneity, three-dimensional (3D) techniques were suggested (3). Our group has used VCG for VR studies for more than a decade, initially to study conditions in which clinically significant VR changes were known to occur, exemplified by coronary occlusion-induced ischemia and ventricular pacing-induced cardiac memory (19, 24, 29, 30) . VCG provides both 3D QRST-derived "conventional" ECG measures [e.g., the QRS, QT, and T-peak to T-end (Tp-e) intervals], and information on other global aspects of VR, as reflected by T vector and T-vector loop morphology parameters. VCG also outlines the 3D relationship between depolarization and repolarization forces (3, 19, 24, 25, 29, 30, 31) and has proven superior to ECG for detection of VR changes in the long QT syndrome and of cardiac memory, as induced by ventricular pacing or appearing after Wolff-Parkinson-White ablation (6, 30, 31) .
Although there are many factors that affect VR, the most important physiological factors are heart rate (HR), autonomic nervous system (ANS) activity, age, and sex (4, 18) . As first part of a project to evaluate the influence of such factors on VCG parameters of VR, we recently studied the effect of HR increase by atrial pacing in healthy individuals (27) . The purpose of this second part of the project, performed in healthy adult subjects, was primarily to evaluate the VR response to modulated ANS activity, applying VCG analysis. A pharmacological approach was chosen (see Discussion), and the hypothesis was that ANS modulation would affect VR beyond the pure HR-related effects and differently, depending on how it was achieved, by ␤-adrenoceptor (␤-AR) stimulation vs. by muscarinic receptor blockade. Since there is a well-known sex-related difference in VR duration [QT and corrected QT (QTc)], a secondary purpose was to compare the VR response to ANS modulation in men and women. The spatial area under the curve formed by the moving heart vector during the JT interval Tavplan
Glossary

ANS
The mean distance between the periphery of the T loop and both sides of the preferential plane Tazimuth
The angle of the maximum T vector in the transverse plane (0°left, ϩ90°front, Ϫ90°back, and 180°right) Teigenvalue
The squared quotient between the two largest perpendicular axes (eigenvalues) of the T loop in the preferential plane
The angle of the maximum T vector in the cranio-caudal direction by us defined from 0°(caudal direction) to 180°(cranial direction) Tp-e T peak to T end, the last part of the QT interval and final repolarization VCG Vectorcardiography VG Ventricular gradient or QRST area is the spatial area under the curve formed by the moving heart vector during the QT interval VR Ventricular repolarization 3D Three-dimensional
METHODS
Subjects
Thirty-one healthy male (16) and female (15) volunteers were recruited to provide complete data sets in at least 26 of them (see Statistics). Care was taken to enroll similar proportions of male and female subjects. They fulfilled the following criteria: 20 -45 yr of age; body mass index (weight/height 2 ) of 19 -27 kg/m 2 ; absence of acute or chronic illness; no family history of sudden cardiac death; no concomitant medication, except for contraceptives; no history of drug addiction, alcohol, or anabolic steroid abuse or habitual use of tobacco; and no relation to the study. Use of a reliable method for birth control in female subjects was required. Normal physical findings, including blood pressure, a normal resting ECG [QT HR corrected according to Fridericia (QTcF) Յ 450 ms], and normal laboratory assessments, including electrolytes, were also required.
The study protocol and procedure was performed following the principles of the Declaration of Helsinki and approved by the regional ethics committee. Written consent was obtained from all participants.
Procedure and Protocol
The study was performed in a hospital setting. The subjects' eligibility was reassessed when they arrived fasting at the clinic before 8 AM. They were comfortably rested in the supine position, and surface electrodes for VCG recording were applied, as were an arm cuff for blood pressure measurement and a fingertip sensor for continuous pulse plethysmographic monitoring. A peripheral venous cannula was inserted for administration of pharmacological substances. No blood samples were obtained during the procedure. Pharmacological modulation of ANS activity was achieved by sympathetic (␤-AR) stimulation with isoprenaline (Iso) infusion and subsequent parasympathetic blockade (muscarinic receptors) with atropine (Atr) and sympathetic (␤-AR) activity blockade with propranolol ( Fig. 1; phases 1-7 ). This sequence was chosen because of the prolonged effects of Atr and propranolol (AϩP), which precluded randomization. At each phase of the Iso infusion, the same procedure was followed: after 5 min, steady-state VCG and finger plethysmography were sampled during silence and closed eyes for 5 min and followed by blood pressure measurement.
Baseline 1 (phase 1). Infusion of sodium-chloride (9 mg/ml) was initiated, and, after 15 min of supine rest, recordings were made.
Iso (phases [2] [3] [4] . The sodium-chloride infusion was replaced by 0.01-0.1 g·kg Ϫ1 ·min Ϫ1 Iso infused with increasing flow rate until three targeted steady-state HRs were reached (see RESULTS for actual HRs); 75 Ϯ 5 beats/min (Iso 1), 95 Ϯ 5 beats/min (Iso 2), and 120 Ϯ 5 beats/min (Iso 3). At the third step, no further dose increase was made after three consecutive increases of the infusion rate by 10 g/h Fig. 1 . An overview of the protocol, including the average heart rate (HR), at each steady-state level and a specification of the periods for analysis of the vectorcardiography (VCG), which was recorded continuously. Bl, baseline; Iso, isoprenaline; Atr, atropine; bpm, beats/min; AϩP, atropine ϩ propranolol. each during 3-5 min without effect on HR, even if the target HR was not reached. Instead, a recording was made at the maximum HR achieved.
Baseline 2 (phase 5). The Iso infusion was turned off, and effects were allowed to wean off during 30 -45 min. The subjects remained in the supine resting position until HR and blood pressure were judged to be stable within a physiological resting range, after which recordings were made.
Atr (phase 6). Pharmacological inhibition of the parasympathetic limb of the ANS (muscarinic receptor blockade) was achieved by administration of Atr (0.04 mg/kg) intravenously over 30 s. After 4 min of HR adaptation, recordings were made.
Propranolol (phase 7). Thereafter, 0.2 mg/kg propranolol was given as an intravenous bolus over 30 s, followed by 8 min of HR adaptation and subsequent recordings (AϩP). The AϩP doses administered were those required to reach complete pharmacological blockade of the sinus node, according to Jose et al. (15, 16) .
VCG
A CoroNet II system (Ortivus AB, Danderyd, Sweden) was connected to eight electrodes positioned according to the Frank orthogonal lead system (X, Y, and Z). VCG was recorded continuously, but interventions were marked for offline assessment of the relevant time periods and used both for analysis of 3D-based QRST intervals and for QRS and T vector, as well as T-vector loop analyses. The methods for recording, interval measurements, and other analyses follow the same principles as described previously and were performed using a customized software (19, 24, 25, 27, 29 -31) . Five 1-min averaged 3D PQRST complexes were constructed from all cardiac cycles recorded during each 5-min steady-state phase of the study. The time resolution was increased during the first 4 min following Atr injection: from the beginning of HR increase, six periods of 10-s VCG recordings were analyzed (A1-A6); A1-A3 were analyzed during the first minute of HR increase, followed by A4 -A6 at constant HR with 1-min interval between each step.
The averaged 3D QRST complex was used for assessing the QRS, QT, and Tp-e intervals, as in a standard ECG. To allow comparisons with other studies, QT was HR corrected according to Bazett (QTcB) as well as Fridericia (QTcF): QTcB ϭ QT/RR 1/2 and QTcF ϭ QT/RR 1/3 (RR in seconds). VG (QRST area), QRSarea, and Tarea (Vs), which are the spatial areas under the curve formed by the moving heart vector during the QT, QJ, and JT intervals, respectively, were computed from the QRST complex in the three orthogonal planes:
, and Tarea ϭ (Tx 2 ϩ Ty 2 ϩ Tz 2 ) 1/2 (Vs) (Fig. 2) . The amplitude of the maximum QRS and T vectors (mV) in space (QRSamplitude and Tamplitude, respectively) were defined as well as their relation, i.e., the QRS-T angle (°). Also, the QRS-T area angle was defined as the angle between the QRSarea vector and the Tarea vector, both on a scale from 0 to 180°. Generally, wider angles suggest that repolarization is abnormal relative to the QRS vector, although there is a wide range for normality as well as a gray zone between "normal" and "abnormal" (35) . In addition to amplitude, the T vector direction was assessed by Televation [°; the angle of the maximum T vector in the cranio-caudal direction by us defined from 0°(caudal direction) to 180°(cranial direction)] and Tazimuth (°; the angle of the maximum T vector in the transverse plane). T vector-loop (from here: T loop) morphology was evaluated by Tavplan (V; the mean distance between the periphery of the T loop and both sides of the preferential plane) and Teigenvalue [unitless; the squared quotient between the two largest perpendicular axes (eigen values) of the T loop in the preferential plane]. Reproducibility data have been reported previously (24, 29) .
Statistics
The number of participants was chosen to enable detection of a change in the conventional conduction intervals (QRS and QT intervals) of Ͻ10 ms with a power of 90%, when data from 26 complete procedures were obtained. Mean (SD) or median (interquartile range) was used for descriptive purposes. Friedman's test for repeated measurements was used for analysis of the overall effects during the seven steady-state phases, Bl 1-AϩP, as well as during Bl 2-A3 and A3-A6. Wilcoxon signed rank test was used for post hoc comparison of data from two specific phases. The Mann-Whitney U-test was used for testing for sex differences, both at baseline and with regard to the responses to interventions. Due to multiple statistical testing, the significance level was set at P Ͻ 0.01.
RESULTS
Thirty-one subjects (16 men and 15 women) were recruited; mean Ϯ SD age was 25 Ϯ 4 yr, and body mass index was 22.5 Ϯ 2.3 kg/m 2 . Complete data sets were obtained from 26 participants, and electrophysiological measurements from 27 (12 men and 15 women). One subject had a baseline pulse rate Ͼ90 beats/min. The protocol was not completed in three other subjects due to recording problems (one case) and adverse drug effects in two (transient slurred speech during Iso infusion in one subject and palpitations after Atr in the other). Mean Ϯ SD for the overall time needed to complete the study protocol for the subjects was 163 Ϯ 17 min.
The overall statistical analyses applying Friedman's test to the seven steady-state phases (Bl 1 to AϩP) showed that all parameters changed significantly during the protocol (P Ͻ 0.0001, except Tavplan, P ϭ 0.009). The mean values were almost identical when based on available data from all 31 participants and 27 with complete data sets. Baseline data are shown in Table 1 .
␤-AR Stimulation: Iso Infusion
See Table 1 and Fig. 3 . The mean Ϯ SD time from the start of infusion to Iso 1, 2, and 3 measurements was 24 Ϯ 13, 50 Ϯ 17, and 72 Ϯ 16 min, respectively. The attained mean Ϯ SD HR was 75 Ϯ 3, 96 Ϯ 4, and 114 Ϯ 8 beats/min, and the infusion rate was 0.8 Ϯ 0.4, 1.6 Ϯ 0.5, and 2.2 Ϯ 0.5 g/min, respectively. Target HRs were reached by all at the first two levels, but not all subjects reached the third.
There were minor changes in mean arterial pressure. Most VCG variables changed significantly: QRSamplitude, Televation, Tavplan, and Teigenvalue were the exceptions (Table 1) . In summary, although the absolute value of VR duration (QT) decreased (Fig. 3A) , its latter part (Tp-e) and, consequently, the ratio of Tp-e to QT (Tp-e/QT) as well as QTc increased. QTcB exceeded 500 ms in 8 subjects and the Tp-e/QT was Ͼ 0.28 in 20 (see DISCUSSION) . Furthermore, since the QRSarea and Tarea decreased and the angle between them (QRS-T area angle) widened, VG, which is the vector sum of QRSarea and Tarea, also decreased (Fig. 3B) . In addition, the T vector turned more anteriorly, and its amplitude decreased. Figure 4 illustrates ECG and Tloop alterations in one subject during this part of the protocol.
Muscarinic and ␤-AR Blockade
See Table 2 and Fig. 5 . The mean Ϯ SD HR at Bl 2 was 66 Ϯ 10 beats/min and increased by 67% to 110 Ϯ 9 beats/min at steady state after Atr injection. Figure 5 illustrates the dynamics of the changes immediately following Atr injection: as HR increased there was a paradoxical early prolongation of the QT interval at A1 (Fig. 5, A and B , P Ͻ 0.001), compared with Bl 2, followed by rate adaptation and a decrease during the first minute. This paradoxical QT prolongation was fully reflected by the Tp-e increase ( Fig. 5C , P Ͻ 0.001), which remained prolonged and resulted in the highest mean value of the Tp-e/QT of 0.26 at A4 (P Ͻ 0.001). On the other hand, QTcB reached its highest value at A3 (Fig. 5D , P Ͻ 0.001) and then decreased and stabilized within 2 min. In fact, QTcB increased to Ͼ500 ms in 14 subjects and the Tp-e/QT was Ͼ0.28 in 9 (6 had both). Furthermore, VG and Tarea decreased as HR increased during A1-A3 (Fig. 5 , E and F, P Ͻ 0.001) and remained unchanged during A4 -A6 at constant HR. In addition (but not shown), while Tavplan increased at A1 (P ϭ 0.001) and remained more or less constant through A6, Teigenvalue decreased mainly in parallel with the HR increase (P Ͻ 0.001).
During the 5-min VCG recording before the injection of propranolol, mean HR decreased minimally from 112 to 109 beats/min. After the administration of propranolol, the socalled intrinsic HR was achieved by pharmacological blockade of the ANS (15, 16) and was 94 Ϯ 9 beats/min. Mean arterial pressure increased by 12% after Atr and remained the same after propranolol. There were significant parameter changes during one or both phases, except for Tp-e and Tazimuth (both unchanged) ( Table 2) . (27) . Iso, isoprenaline. See Glossary for definition of parameters. *P Յ 0.05, †P Յ 0.01, and ‡P Ͻ 0.001, uncorrected P values. In summary, following Atr, there were expected changes oriented toward the "adrenergic" (sympathetic) direction, which were counteracted (as regards QRSamplitude, QRSarea, QT, QTcB, Tarea, Tamplitude, Televation, QRS-T area angle, VG, and Teigenvalue) or fully reversed (as regards QRS and QTcF intervals) by propranolol, except for Tavplan, which increased further.
Sex Differences
At baseline, significant differences were observed for the QRS interval, Tamplitude, Tarea, and VG; these parameters were significantly larger in men (QRS: 108 Ϯ 7 vs. 90 Ϯ 7 ms, Tamplitude: 0.69 Ϯ 0.16 vs. 0.45 Ϯ 0.08 mV, Tarea 93 Ϯ 22 vs. 58 Ϯ 10 Vs; and VG 116 Ϯ 32 vs. 82 Ϯ 16 Vs; P Ͻ 0.001 for all comparisons). However, we did not observe any significant sex-related difference in the responses during the protocol.
DISCUSSION
Autonomous nervous activity is essential for physiological adaptation, but also crucial for some congenital and acquired conditions with increased propensity for life-threatening arrhythmias, strongly linked to VR alterations, e.g., the long QT syndrome (26) . Understanding of the VR response in health and disease is, therefore, of both theoretical and practical importance. In this study, the complex VR response to pharmacological perturbations of ANS activity was assessed noninvasively by VCG in healthy adult men and women. The main findings were as follows: 1) by increasing HR, ␤-AR stimulation with incremental Iso infusion decreased HR-dependent parameters, reflecting the total heterogeneity of VR (Tarea) and action potential morphology (VG); 2) in contrast, Iso infusion prolonged QTcB and increased the Tp-e/QT to levels observed in conditions with increased arrhythmia risk, such as congenital and acquired long QT syndromes, thereby mimicking pathological conditions; 3) HR acceleration after muscarinic blockade with Atr was accompanied by a transient paradoxical QT prolongation and delayed HR adaptation of parameters, reflecting the total heterogeneity of VR (Tarea) and action potential morphology (VG); and 4) ␤-AR blockade with propranolol only partly reversed the effects of Atr.
Methodological Aspects
ANS modulation can, in humans, be achieved by physical and mental stress testing, change in posture, transcutaneous and direct nerve stimulation, and by pharmacological means. Iso is a reference substance in the study of ␤ 1 -AR effects on the heart, and there are Ͼ 14,000 entries in PubMed on this topic, including studies "from molecule to man".
Iso effects and tentative mechanisms. In our laboratory's recent work, increasing HR from 80 to 120 beats/min by atrial pacing shortened QT (as expected) and decreased both VG and Tarea in linear relation to HR changes (27) . The directional changes in these parameters as HR increased during Iso infusion were, therefore, expected, but their response to HR increase following ␤-AR stimulation was not linear (Fig. 3B) , which may reflect differences in the rate dependency of ␤-adrenergic modulation of currents affecting repolarization (23), as discussed briefly below. In addition, both QTcB (which changed minimally during atrial pacing; no case Ͼ 450 ms at HR 100 -120 beats/min), and Tp-e/QT (which was HR inde- pendent; no case Ͼ 0.26), increased significantly by Iso (P Ͻ 0.001; Fig. 3A ) (27) . Indeed, QTcB increased to Ͼ500 ms in 8 subjects and Tp-e/QT to Ͼ0.28 in 20, responses that are recognized as associated with increased propensity for malignant arrhythmias and cannot be explained by HR increase alone (12) . How can these effects be explained based on the present knowledge from in vitro experiments?
Two downstream pathways are known to mediate electrophysiological effects of ␤-AR stimulation, the cAMP/PKA pathway and CaMKII (10) . PKA modulates the function of the L-type Ca 2ϩ channel (I CaL ), the cardiac ryanodine receptor type 2, the ␣-subunit of the cardiac Na ϩ channel (I Na ), the sodium-calcium exchanger, the slow component of the delayed rectifier current (I Ks ), and Ca 2ϩ -activated chloride current (2, 14) . While ␤-AR activation of I Ks results in shortening of VR, activation of I CaL shifts the plateau of the action potential to more positive values and prolongs VR (14) . Furthermore, CaMKII affects the function of both the membranous I CaL and the intracellular ryanodine receptor type 2, phospholamban, as well as the sarco/endoplasmic reticulum Ca 2ϩ -ATPase 2, which regulates the release and recycling of Ca 2ϩ to the sarcoplasmic reticulum, crucial for the electromechanical coupling (5, 10) . In addition, recent work has shown that CaMKII regulates Na ϩ channels, e.g., by enhancing late I Na , which may prolong action potential duration (28) . Our observations on QTcB and Tp-e/QT may be explained by either PKA-modulated I CaL or CaMKII-mediated effects, or even a combination, in which case the duration of sympathetic stimulation seems essential (11) .
Animal studies have shown that T peak and T end almost coincide with the earliest and latest end of repolarization, respectively. Tp-e has, therefore, been suggested as an index of global (or total) dispersion of repolarization (here synonymous with VR heterogeneity) (20, 33, 34) . Based on this assumption, the prolongation of Tp-e following Iso infusion in our study could be interpreted as a sign of heterogeneous concentration of ␤-ARs and/or diverse response to Iso in different parts of the myocardium via other mechanisms, such as heterogeneous distribution of ion channels.
Effects of muscarinic and ␤-AR blockade. The reason for choosing several shorter sampling periods for the initial part of this phase of the protocol was that the very rapid onset of vagal withdrawal and sympathetic activation after a bolus of Atr allowed us to assess the dynamics with a reasonably good time resolution and faster than is possible with Iso to the same level of sympathetic activity as judged by the HR response. It also gave us the opportunity to find out if the response in humans was similar to that in previous experimental studies. Paradoxical prolongation of the action potential duration and the QT interval has previously been observed a few seconds following administration of adrenergic drugs in both guinea pig papillary muscle and dogs (1, 21) . This initial prolongation has been suggested to be due to faster activation of I CaL than of I Ks by PKA (17) . This is, to the best of our knowledge, the first time that paradoxical QT prolongation has been documented in humans following ␤-AR activation, here induced by muscarinic receptor blockade with Atr.
The mechanism behind the effects of muscarinic receptor stimulation is less well understood compared with ␤-AR stimulation. It is, however, known that ACh has an antagonistic effect on ␤-AR-stimulated I CaL and Iso-induced activation of I K (14) . In addition, muscarinic cholinergic agonists inhibit release of norepinephrine from sympathetic nerve terminals (22) . Therefore, it is conceivable that, even following Atr injection and inhibition of muscarinic receptors, the faster activation of I CaL should be the main underlying mechanism for the brief and transient paradoxical QT prolongation.
In addition, our observation that, shortly after Atr injection, Ͼ50% of the individuals had a prolonged QTcB Ͼ 500 ms, a Tp-e/QT Ͼ 0.28, or both, might indicate that vagal withdrawal can be as important for increasing the propensity for ventricular arrhythmias in patients with long QT syndrome as sympathetic stimulation in the presence of retained vagal activity. This issue clearly needs further study.
Moreover, as partly illustrated in Fig. 6 , a comparison of Atr vs. Iso 3, two steady-state phases with no significant difference in HR, reveals that the QT, QTc, and Tp-e intervals were significantly longer; Tarea, VG, and Tp-e/QT larger; and the QRS-T angle and area angle wider during Iso 3 (P Ͻ 0.001). Iso at the highest dose level thus had more profound effects on VR than the unopposed intrinsic sympathetic activity following Atr injection, although the effect on the sinus node appeared similar (see also Table 2 ).
Finally, during the last phase of our study with muscarinic and ␤-AR blockade, following AϩP injection, it is presumably ␣-AR activation that mainly modulates the electrical activity of the myocardium. These receptors are linked to PLC and PLD and affect the function of different ion currents, such as I CaL and T-type Ca 2ϩ current, I Ks , the transient outward current, the inward rectifying current (I K1 ), the Na ϩ /H ϩ exchanger, and Na ϩ -K-ATPase (2). Moreover calcium ions have second-messenger function and can directly activate CaMKII (14) . On the other hand, when comparing AϩP with Iso 2, the prominent stimulation of ␤-AR at Iso 2 resulted in longer QT, QTcB, Tp-e, and larger Tp-e/QT and Tarea than at AϩP (P Ͻ 0.001), despite similar HRs (Fig. 6) .
Conclusions
In addition to the expected HR adaptation, the VR response to ␤-AR stimulation with incremental infusion of Iso and to muscarinic receptor blockade with Atr included components previously recognized in conditions with increased arrhythmia risk, such as congenital and acquired long QT syndromes. As regards VR, a substantial overlap between physiological and pathophysiological electrophysiology, therefore, seems to exist.
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